F Cardoso

Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.

S Michiels, B Asselain, J Bogaerts, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

E. Rutgers, F. Cardoso, F. Penault-Llorca, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

F. Cardoso, F. Penault-Llorca, S. Zackrisson, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?

C Sotiriou, C. Sotiriou, D. Larsimont, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

High concordance of protein (by IHC), gene (by FISH; HER2 only), and microarray readout (by TargetPrint) of ER, PgR, and HER2: results from the EORTC 10041/BIG 03-04 MINDACT trial.

J Bogaerts, A. Glas, E. Rutgers, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Bortezomib/docetaxel combination therapy in patients with anthracycline-pretreated advanced/metastatic breast cancer: a phase I/II dose-escalation study

M. Piccart, J. Baselga, F. Cardoso, 2008, British Journal of Cancer.

4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)†

N S El Saghir, L Biganzoli, N Harbeck, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

F. Cardoso, F. Penault-Llorca, A. Thompson, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

L. Fallowfield, M. Castiglione, F. Cardoso, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Cyclin E1 (CCNE1) and E2 (CCNE2) as prognostic and predictive markers for endocrine therapy (ET) in early breast cancer.

M Paesmans, C Sotiriou, F Cardoso, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Identification of a low-risk subgroup of HER-2-positive breast cancer by the 70-gene prognosis signature

S. Linn, F. Cardoso, Philippe Bédard, 2009, British Journal of Cancer.